Inventor
SHAK STEVEN
US32 patents
⚠️ This page may combine multiple inventors who share the name “SHAK STEVEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GENOMIC HEALTH INC
17 patentsUS7930104B2Apr 19, 2011
Predicting response to chemotherapy using gene expression markers
GENOMIC HEALTH INC91 citations97
US7871769B2Jan 18, 2011
Gene expression markers for predicting response to chemotherapy
GENOMIC HEALTH INC47 citations96
US7526387B2Apr 28, 2009
Expression profile algorithm and test for cancer prognosis
GENOMIC HEALTH INC47 citations96
US8034565B2Oct 11, 2011
Gene expression markers for breast cancer prognosis
GENOMIC HEALTH INC15 citations92
US7939261B2May 10, 2011
Expression profile algorithm and test for cancer prognosis
GENOMIC HEALTH INC25 citations92
US7723033B2May 25, 2010
Prediction of likelihood of cancer recurrence
GENOMIC HEALTH INC28 citations92
US7622251B2Nov 24, 2009
Molecular indicators of breast cancer prognosis and prediction of treatment response
GENOMIC HEALTH INC31 citations92
US10260104B2Apr 16, 2019
Method for using gene expression to determine prognosis of prostate cancer
GENOMIC HEALTH INC2 citations70
US11220715B2Jan 11, 2022
Gene expression markers for breast cancer prognosis
GENOMIC HEALTH INC0 citations62
US12412642B2Sep 9, 2025
Method to use gene expression to determine likelihood of clinical outcome of renal cancer
GENOMIC HEALTH INC0 citations61
US11776664B2Oct 3, 2023
Method to use gene expression to determine likelihood of clinical outcome of renal cancer
GENOMIC HEALTH INC0 citations61
US10892038B2Jan 12, 2021
Method to use gene expression to determine likelihood of clinical outcome of renal cancer
GENOMIC HEALTH INC0 citations61
US11551782B2Jan 10, 2023
Gene expression profile algorithm for calculating a recurrence score for a patient with kidney cancer
GENOMIC HEALTH INC0 citations56
US11011252B1May 18, 2021
Gene expression profile algorithm and test for determining prognosis of prostate cancer
GENOMIC HEALTH INC0 citations56
US10181008B2Jan 15, 2019
Gene expression profile algorithm for calculating a recurrence score for a patient with kidney cancer
GENOMIC HEALTH INC1 citations56
US10619215B2Apr 14, 2020
Prediction of likelihood of cancer recurrence
GENOMIC HEALTH INC0 citations52
US9944990B2Apr 17, 2018
Gene expression markers for breast cancer prognosis
GENOMIC HEALTH INC0 citations51
GENENTECH INC
7 patentsUS6627196B1Sep 30, 2003
Dosages for treatment with anti-ErbB2 antibodies
GENENTECH INC209 citations97
US7371379B2May 13, 2008
Dosages for treatment with anti-ErbB2 antibodies
GENENTECH INC86 citations96
US7892549B2Feb 22, 2011
Treatment with anti-ErbB2 antibodies
GENENTECH INC60 citations94
US10280228B2May 7, 2019
Treatment with anti-ErbB2 antibodies
GENENTECH INC16 citations93
US10160811B2Dec 25, 2018
Treatment with anti-ErbB2 antibodies
GENENTECH INC17 citations93
US7297526B2Nov 20, 2007
Human DNase
GENENTECH INC18 citations92
US6348343B2Feb 19, 2002
Human DNase I variants
GENENTECH INC48 citations89
BAKER JOFFRE B
4 patentsUS8868352B2Oct 21, 2014
Predicting response to chemotherapy using gene expression markers
BAKER JOFFRE B10 citations83
US8148076B2Apr 3, 2012
Gene expression profiling of EGFR positive cancer
BAKER JOFFRE B10 citations82
US9605318B2Mar 28, 2017
Gene expression markers for predicting response to chemotherapy
BAKER JOFFRE B1 citations50
US8273534B2Sep 25, 2012
Predictors of patient response to treatment with EGF receptor inhibitors
BAKER JOFFRE B0 citations38